Drug Research

Clovis Oncology claimed an update to the ongoing regulatory review for the Marketing Authorization Application (MAA) for Rucaparib tablets as monotherapy for the treatment of advanced…
Read More...

McKesson Specialty Health oncology and complex care pharmacy services company has been finalized by the Janssen Pharmaceutical Companies of Johnson & Johnson which is considered the…
Read More...

Vertex Pharmaceuticals affirmed initiating the first Phase 3 study of VX-659,  tezacaftor and ivacaftor as an investigational triple combination regimen for people with cystic fibrosis…
Read More...

U.S FDA had asserted the destruction and recall of large volume of kratom-containing dietary supplements that is ideally manufactured and distributed nationwide under the Brand names…
Read More...

Evidenced-based dual diagnosis treatment facility, Chiron Recovery executed a MAT program for the treatment of opioid addiction. Addiction is a chronic disease and just like other…
Read More...

Global pharmaceutical company, Glenmark Pharmaceuticals ventured into an exclusive agreement with Sam Chun Dang Pharma. Co. Ltd. (SCD) to develop, manufacture and market a portfolio of…
Read More...

Medical device company, INVO Bioscience sought FDA clearance for Intravaginal Culture System, INVOcell asserted that Alabama Fertility has augmented its scope of reproductive treatments…
Read More...

Biotechnology company developing innovative products to fill women's unmet healthcare needs, Evofem Biosciences asserted that the U.S FDA has extended Fast Track designation for Amphora…
Read More...

GSK presented at the Center for Disease Control and Prevention Advisory Committee on Immunization Practices meeting that FLUARIX QUADRIVALENT exhibited 63.2% efficacy against moderate…
Read More...

Nativis, a clinical-stage therapeutic device company developing non-sterile, non-invasive, non-thermal treatments for cancers and other grave diseases asserted that it has received a…
Read More...

Qiagen approved a decision by the U.S centers for Disease Control to use modern blood-based tests (IGRA) for tuberculosis (TB) screening. The CDC Division of Global Migration and…
Read More...

Impax Laboratories asserted the roll out of generic version of Solodyn (minocycline HCl) extended-release tablets, 65 mg and 115 mg. Minocycline HCl extended-release tablets, 65 mg…
Read More...

Mylan N.V, which is a global pharmaceutical company asserted receipt of tentative approval from the U.S Food and Drug Administration under the U.S President's Emergency Plan for AIDS…
Read More...

PTC Therapeutics asserted that the office of New Drugs of the U.S Food and Drug Administration has reaffirmed the FDA's former position quashing PTC's appeal of the Complete Response…
Read More...

Maker of innovative, needle-free injection technology,  PharmaJet asserted venturing into a global license agreement with  Genexine, for the development and commercialization of DNA…
Read More...

Evolus asserted the presentation of data from the Phase III comparative Clinical trial of its investigational prabotulinumtoxinA 900 kilodalton (kDa) neuromodulator at the American…
Read More...

LEO Pharma asserted new data exhibiting long-term improvements in psoriasis on nail iwth Kyntheum when compared to placebo or ustekinumab. Psoriasis on nail is usually tough to treat…
Read More...

The Janssen Pharmaceutical Companies of Johnson and Johnson asserted extrapolation of data that exemplified 90 percent improvement in the Psoriasis Area and Severity Index (PASI 90) at…
Read More...

Optimal Research, a patient identification and trial activation service provider, and OncoLens, a software as a service (SaaS) tumor board solution asserted to partner to bring…
Read More...

DanDrit Biotech USA, Inc. asserted the completion of acquisition of Enochian Biopharma. DanDrit possesses a perpetual, fully paid up, royalty free, sublicensable, exclusive, license to…
Read More...